BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11231705)

  • 1. Early switch and early discharge strategies in patients with community-acquired pneumonia: a meta-analysis.
    Rhew DC; Tu GS; Ofman J; Henning JM; Richards MS; Weingarten SR
    Arch Intern Med; 2001 Mar; 161(5):722-7. PubMed ID: 11231705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.
    Lee RW; Lindstrom ST
    Respirology; 2007 Jan; 12(1):111-6. PubMed ID: 17207035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of processes and outcomes of pneumonia care between hospitalists and community-based primary care physicians.
    Rifkin WD; Conner D; Silver A; Eichorn A
    Mayo Clin Proc; 2002 Oct; 77(10):1053-8. PubMed ID: 12374249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia.
    Ramirez JA; Vargas S; Ritter GW; Brier ME; Wright A; Smith S; Newman D; Burke J; Mushtaq M; Huang A
    Arch Intern Med; 1999 Nov; 159(20):2449-54. PubMed ID: 10665893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial.
    Carratalà J; Garcia-Vidal C; Ortega L; Fernández-Sabé N; Clemente M; Albero G; López M; Castellsagué X; Dorca J; Verdaguer R; Martínez-Montauti J; Manresa F; Gudiol F
    Arch Intern Med; 2012 Jun; 172(12):922-8. PubMed ID: 22732747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial.
    Oosterheert JJ; Bonten MJ; Schneider MM; Buskens E; Lammers JW; Hustinx WM; Kramer MH; Prins JM; Slee PH; Kaasjager K; Hoepelman AI
    BMJ; 2006 Dec; 333(7580):1193. PubMed ID: 17090560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for early discharge of the hospitalized patient with community-acquired pneumonia.
    Siegel RE
    Clin Chest Med; 1999 Sep; 20(3):599-605. PubMed ID: 10516907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-acquired pneumonia team decreases length of stay in hospitalized, low-risk patients with pneumonia.
    Marcos PJ; Restrepo MI; Sanjuàn P; Ferreira-Gonzalez L; Verea-Hernando H
    Hosp Pract (1995); 2013 Aug; 41(3):7-14. PubMed ID: 23948616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of early switch from intravenous to oral antimicrobials in patients with aspiration pneumonia: A prospective observational study.
    Uni M; Nishimura N; Yamano Y; Ishikawa G; Kitamura A; Tomishima Y; Jinta T; Takahashi O; Deshpande G; Chohnabayashi N
    Respir Investig; 2015 Sep; 53(5):225-31. PubMed ID: 26344612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical benefit of in-hospital observation in 'low-risk' pneumonia patients after conversion from parenteral to oral antimicrobial therapy.
    Rhew DC; Hackner D; Henderson L; Ellrodt AG; Weingarten SR
    Chest; 1998 Jan; 113(1):142-6. PubMed ID: 9440581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial.
    Castro-Guardiola A; Viejo-Rodríguez AL; Soler-Simon S; Armengou-Arxé A; Bisbe-Company V; Peñarroja-Matutano G; Bisbe-Company J; García-Bragado F
    Am J Med; 2001 Oct; 111(5):367-74. PubMed ID: 11583639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis.
    Athanassa Z; Makris G; Dimopoulos G; Falagas ME
    Drugs; 2008; 68(17):2469-81. PubMed ID: 19016574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-hospital observation after antibiotic switch in pneumonia: a national evaluation.
    Nathan RV; Rhew DC; Murray C; Bratzler DW; Houck PM; Weingarten SR
    Am J Med; 2006 Jun; 119(6):512.e1-7. PubMed ID: 16750965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization.
    Battleman DS; Callahan M; Thaler HT
    Arch Intern Med; 2002 Mar; 162(6):682-8. PubMed ID: 11911722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of length of stay, total costs, and treatment success between intravenous moxifloxacin 400 mg and levofloxacin 750 mg among hospitalized patients with community-acquired pneumonia.
    Friedman H; Song X; Crespi S; Navaratnam P
    Value Health; 2009; 12(8):1135-43. PubMed ID: 19695010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study.
    DiDiodato G; McArthur L; Beyene J; Smieja M; Thabane L
    Trials; 2015 Aug; 16():355. PubMed ID: 26272324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia.
    Stahl JE; Barza M; DesJardin J; Martin R; Eckman MH
    Arch Intern Med; 1999 Nov; 159(21):2576-80. PubMed ID: 10573047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing and developing strategies for the treatment of community-acquired pneumonia at a community hospital.
    Fok MC; Kanji Z; Mainra R; Boldt M
    Can Respir J; 2002; 9(4):247-52. PubMed ID: 12195270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tailored implementation strategy to reduce the duration of intravenous antibiotic treatment in community-acquired pneumonia: a controlled before-and-after study.
    Engel MF; Bruns AH; Hulscher ME; Gaillard CA; Sankatsing SU; Teding van Berkhout F; Emmelot-Vonk MH; Kuck EM; Steeghs MH; den Breeijen JH; Stellato RK; Hoepelman AI; Oosterheert JJ
    Eur J Clin Microbiol Infect Dis; 2014 Nov; 33(11):1897-908. PubMed ID: 24859925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.